No results founds

2026 (1)

Ivorra A.; Ausin T.; Becerra-Fajardo L.; del Ama A.J.; Minguillon J.; Garcia-Moreno A.; Aguilo J.; Barroso F.O.; Bijnens B.; Camara O.; Capdevila S.; Fernandez R.C.; Davalos R.V.; Divoux J.L.; Eladly A.; Farina D.; Hombravella C.G.; Lopez R.G.; Gonzalez C.A.; Grifols J.; Maglietti F.; Malik S.; Maor E.; Marshall G.; Yus B.M.; Mir L.M.; Moreno J.C.; Navarro X.; Noguera N.; Ozaita A.; Piella G.; Pons J.L.; Quesada R.; Rivera-Gil P.; Rubinsky B.; Garcia A.R.; Ruiz-Vargas A.; Sanchez Sanchez M.; Schneider-Ickert A.; Shu T.; Sanz R.V.; Zhang B.; Revuelta G.. The biomedical engineer's pledge: overview and context. Medical and Biological Engineering and Computing 2026; 64(1): 1-8.

2025 (4)

Bergada-Martinez A.; de los Reyes-Ramirez L.; Martinez-Torres S.; Ciaran-Alfano L.; Martinez-Gallego I.; Maldonado R.; Rodriguez-Moreno A.; Ozaita A.. Sub-chronic administration of AM6545 enhances cognitive performance and induces hippocampal synaptic plasticity changes in naïve mice. British Journal of Pharmacology 2025; : 1-16.

Nizam H., Imtiaz A., Tasneem F., Shakoori F.R., Zulfiqar S., Younas A., Mustafa S., Ghaus A., Zafar A., Nazir A., Sajjad M., Shakoori A.R.. Enhanced cadmium binding ability in response to novel modifications in a Paramecium cadmium metallothionein PMCd1. PLOS ONE 2025; 20(5): .

Di Franco N.; de Tena I.B.; Sanchez-Ruiz A.; Pereda-Velarde A.; Enfedaque F.; Gonzalez-Arias C.; Rio L.M.M.; Bortolozzi A.; Rodriguez-Puertas R.; Costas-Insua C.; Molina-Porcel L.; Vazquez-Oliver A.; Ozaita A.; Guzman M.; Perea G.; Gines S.. Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models. Translational Neurodegeneration 2025; 14(1): .

Vazquez-Oliver A.; Perez-Garcia S.; Romero-Perez R.; Pizarro N.; Galarraga-Shinin D.; Molina-Porcel L.; de la Torre R.; Maldonado R.; Ozaita A.. Targeting dysregulated CB1 receptors in a down syndrome mouse model improves neurological outcomes. Alzheimer's and Dementia 2025; 21(11): .